BioCryst Pharmaceuticals | BCRX - Despesas De Vendas E Administração

Preço das Ações
9.78
Mudança Diária
0.08 0.82%
Mensal
28.52%
Anual
21.49%
Q1 Previsão
9.41




Despesas De Vendas E Administração Alterar Data
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
Chugai Pharma JPY 36.93B 9.04B 2025-12
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
DBV Technologies USD 3.63M 3.18M 2025-09
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Glaxosmithkline GBP 3.56B 650.29M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novavax USD 25.53M 1.34M 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12